Bandaram Pharma

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE875N01036
  • NSEID:
  • BSEID: 524602
INR
34.76
-1.82 (-4.98%)
BSENSE

Dec 05

BSE+NSE Vol: 60

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
EQUITY AND LIABILITIES
No of Months
12
12
12
Share Capital
12.00
12.00
3.00
Share Warrants & Outstandings
Total Reserve
0.65
0.28
0.08
Shareholder's Funds
12.65
12.28
3.08
Minority Interest
3.17
2.79
2.05
Long-Term Borrowings
8.99
4.68
7.65
Secured Loans
2.36
1.78
1.97
Unsecured Loans
6.63
2.89
5.68
Deferred Tax Assets / Liabilities
0.07
0.08
0.05
Other Long Term Liabilities
0
0
0
Long Term Trade Payables
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
Total Non-Current Liabilities
9.06
4.76
7.69
Current Liabilities
Trade Payables
4.36
4.12
0.24
Other Current Liabilities
1.18
0.37
0.37
Short Term Borrowings
8.16
7.53
6.56
Short Term Provisions
0.33
0.22
0.19
Total Current Liabilities
14.03
12.24
7.35
Total Liabilities
38.92
32.06
20.17
ASSETS
Non-Current Assets
0.00
0.00
0.00
Gross Block
5.99
5.91
5.03
Less: Accumulated Depreciation
2.04
1.43
0.00
Less : Impairment of Assets
0.00
0.00
0.00
Net Block
3.95
4.48
5.03
Lease Adjustment
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
Non Current Investments
1.40
1.40
0.00
Long Term Loans & Advances
0.00
0.00
0.00
Other Non Current Assets
2.69
0.11
0.08
Total Non-Current Assets
8.04
5.99
5.11
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
Inventories
8.51
6.47
2.71
Sundry Debtors
18.76
14.52
6.62
Cash and Bank
0.12
0.04
0.16
Other Current Assets
2.30
2.69
2.01
Short Term Loans and Advances
1.20
2.34
3.56
Total Current Assets
30.88
26.06
15.06
Net Current Assets (Including Current Investments)
16.85
13.83
7.71
Total Current Assets Excluding Current Investments
30.88
26.06
15.06
Miscellaneous Expenses not written off
0.01
0.01
0.02
Total Assets
38.92
32.06
20.17
Contingent Liabilities
0.00
0.00
0.00
Total Debt
17.15
12.20
14.20
Book Value per share (adjusted)
10.54
10.23
3.57651053644179
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 40.57% vs -14.08% in Mar 2024

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is -11.83% vs -10.93% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 18.50% vs 73.04% in Mar 2024

Compare Balance Sheet Results of Bandaram Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.00
14.81
-2.81
-18.97%
Share Warrants & Outstandings
Total Reserve
0.65
-2.84
3.49
122.89%
Shareholder's Funds
12.65
11.97
0.68
5.68%
Minority Interest
3.17
0.00
3.17
0.00%
Long-Term Borrowings
8.99
0.00
8.99
0.00%
Secured Loans
2.36
0.00
2.36
0.00%
Unsecured Loans
6.63
0.00
6.63
0.00%
Deferred Tax Assets / Liabilities
0.07
0.00
0.07
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.11
-0.11
-100.00%
Total Non-Current Liabilities
9.06
0.11
8.95
8,136.36%
Current Liabilities
Trade Payables
4.36
0.03
4.33
14,433.33%
Other Current Liabilities
1.18
1.02
0.16
15.69%
Short Term Borrowings
8.16
2.43
5.73
235.80%
Short Term Provisions
0.33
0.00
0.33
0.00%
Total Current Liabilities
14.03
3.48
10.55
303.16%
Total Liabilities
38.92
15.57
23.35
149.97%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
5.99
0.05
5.94
11,880.00%
Less: Accumulated Depreciation
2.04
0.05
1.99
3,980.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
3.95
0.00
3.95
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
3.26
-3.26
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
1.40
4.76
-3.36
-70.59%
Long Term Loans & Advances
0.00
2.00
-2.00
-100.00%
Other Non Current Assets
2.69
0.00
2.69
0.00%
Total Non-Current Assets
8.04
10.02
-1.98
-19.76%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.51
0.00
8.51
0.00%
Sundry Debtors
18.76
2.09
16.67
797.61%
Cash and Bank
0.12
0.00
0.12
0.00%
Other Current Assets
2.30
0.04
2.26
5,650.00%
Short Term Loans and Advances
1.20
3.41
-2.21
-64.81%
Total Current Assets
30.88
5.54
25.34
457.40%
Net Current Assets (Including Current Investments)
16.85
2.06
14.79
717.96%
Total Current Assets Excluding Current Investments
30.88
5.54
25.34
457.40%
Miscellaneous Expenses not written off
0.01
0.00
0.01
0.00%
Total Assets
38.92
15.57
23.35
149.97%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
17.15
2.43
14.72
605.76%
Book Value per share (adjusted)
10.54
8.09
2.45
30.28%
Annual - Borrowings
Borrowings 17.15 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 40.57% vs -14.08% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 3.95 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.83% vs -10.93% in Mar 2024

Annual - Investments
Investments 1.40 Cr
in Mar 2025

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 30.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.50% vs 73.04% in Mar 2024